Olon Constructs Fermentation Facility in Italy
Olon began construction of a GMP facility for biologic APIs in Capua, Italy.
Olon SpA, an API contract development and manufacturing organization (CDMO) and generics supplier, began construction on a new GMP manufacturing facility at its microbial CDMO facility located in Capua, Italy, according to a July 24, 2019 press release.
"I am pleased to announce the start of this GMP capacity expansion just within six months after the acquisition of Capua BioServices. This truly confirms the real opportunity to accelerate growth in Olon's CDMO service positioning and to be recognized as European Leader in the CDMO of microbial fermentation," said Paolo Tubertini, CEO of Olon, in the press release.
The construction of this new GMP facility is associated with a long-term strategic partnership with a large pharmaceutical company. The engineering project is designed to support the manufacture of multiple products, up to commercial scale.
Olon is headquartered in Milan, Italy and has 11 manufacturing facilities in Europe (Italy and Spain), the US (Concord, OH), and India (Mahad).
Source: Olon
Telix Enters Agreement with ImaginAb to Purchase Next-Gen Therapeutic Candidates
Published: January 13th 2025 | Updated: January 13th 2025The transaction adds a pipeline of early-stage drug candidates against high-value targets to Telix’s portfolio, along with other novel targets currently in the discovery stage.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
